The Shifting Sands of Lung Cancer Screening The Shifting Sands of Lung Cancer Screening
An analysis of lung cancer screening since March 2021, when eligibility criteria were expanded, shows that significantly more Black men have been screened, but not women or undereducated people.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 19, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mark Cuban Pharmacy Offers Imatinib at a Fraction of the Cost Mark Cuban Pharmacy Offers Imatinib at a Fraction of the Cost
Mark Cuban has launched a discount pharmacy offering generic drugs at a substantially lower cost than current retail pricing, and currently has several cancer drugs in the formulary.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Radiotherapy Improves Local Control of Advanced Sinus Cancer Radiotherapy Improves Local Control of Advanced Sinus Cancer
Intensity-modulated radiotherapy allows for higher radiation doses while sparing surrounding tissue. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pembrolizumab for Melanoma Bittersweet, Doctor Says Pembrolizumab for Melanoma Bittersweet, Doctor Says
Discussing adjuvant pembrolizumab in KEYNOTE-716, one expert said, ' This is a bitter pill to swallow because you ' re treating people longer and you ' re not sure if you ' re really helping them. 'Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Pelvic Tumor Radiation Regimen Safe, Effective for Palliation New Pelvic Tumor Radiation Regimen Safe, Effective for Palliation
The regimen splits the difference between more conventional approaches. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

US Hot, Cold Spots of Young-Onset CRC May Help Target Interventions US Hot, Cold Spots of Young-Onset CRC May Help Target Interventions
Mortality from young-onset colorectal cancer varies across the United States, with hot spots of higher rates and cold spots of lower rates, which may help guide future interventions, say researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 15, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

FDA OKs Crizotinib for Myofibroblastic Tumors FDA OKs Crizotinib for Myofibroblastic Tumors
The tyrosine kinase inhibitor has already been approved for certain patients with non-small cell lung cancer and anaplastic large cell lymphoma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Risky Business: Most Cancer Drugs Don't Reach the Market Risky Business: Most Cancer Drugs Don't Reach the Market
A new analysis finds that a cancer drug tested in a phase 1 trial has about a 6% chance of eventual FDA approval, but some factors may up those odds.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Drugging the Undruggable Drugging the Undruggable
Long thought to be untreatable, KRAS-mutant cancers are now the target of two new drugs.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New KRAS Inhibitor Shows Promise in NSCLC New KRAS Inhibitor Shows Promise in NSCLC
The KRAS (G12C) inhibitor adagrasib induced an objective response in about one out of three patients with previously treated KRAS (G12C) –mutated non–small cell lung cancer (NSCLC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Amazon Involved With New Cancer Vaccine Clinical Trial Amazon Involved With New Cancer Vaccine Clinical Trial
The trial is aimed at finding"personalized vaccines" to treat breast cancer and melanoma.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lymph Node Density Predicts Survival in Gastric Cancer Lymph Node Density Predicts Survival in Gastric Cancer
Adding lymph node density to tumor staging could improve accuracy. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Heartache of Bereavement Can Be Fatal in Heart Failure The Heartache of Bereavement Can Be Fatal in Heart Failure
The loss of a close family member, regardless of how they died, increased heart failure mortality both short- and long-term, a new study found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 12, 2022 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Patients Taking Methotrexate Face New Barriers Under Roe v Wade Decision Patients Taking Methotrexate Face New Barriers Under Roe v Wade Decision
Pharmacists in some parts of the country are denying access to the oral abortifacient methotrexate; White House and associations are taking steps to protect access to needed medications.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 12, 2022 Category: Cancer & Oncology Tags: Rheumatology News Source Type: news

New Algorithm Can ID Critical Cancer Mutations in DNA New Algorithm Can ID Critical Cancer Mutations in DNA
An algorithm that works like facial recognition tech can identify cancer"patterns" in DNA that could help doctors choose more effective treatments and save more lives someday.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news